Company intelligence / Profile preview
Shenzhen Huayao Kangming Biopharmaceutical Co., Ltd.
- Ownership
- Private
- Development stage
- Other
01
Overview
Shenzhen Huayao Kangming Biopharmaceutical is a high-tech enterprise specializing in research, development, production and sales of innovative biopharmaceuticals. The company has a leading position within China's biopharma sector with a focus on oncology and metabolic diseases. Its pipeline includes at least one clinical-stage program (oncolytic vaccinia virus) targeting neoplasms; it collaborates with major academic hospitals for clinical trials.[6]
- Therapeutic areas
- OncologyEndocrinologyNephrology
- Modalities
- Oncolytic viruses
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Shenzhen Huayao Kangming Biopharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Huayao Kangming Biopharmaceutical Co., Ltd..